Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Numerai GP LLC

Numerai GP LLC boosted its position in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 728.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,442 shares of the medical instruments supplier's stock after purchasing an additional 1,268 shares during the quarter. Numerai GP LLC's holdings in Mettler-Toledo International were worth $1,765,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Alliancebernstein L.P. grew its holdings in Mettler-Toledo International by 9.9% in the 4th quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier's stock valued at $713,627,000 after buying an additional 52,726 shares in the last quarter. Geode Capital Management LLC grew its holdings in Mettler-Toledo International by 2.0% in the 4th quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock valued at $682,340,000 after buying an additional 11,032 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Mettler-Toledo International by 6.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier's stock valued at $557,680,000 after buying an additional 25,873 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Mettler-Toledo International by 36.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock valued at $444,327,000 after buying an additional 96,300 shares in the last quarter. Finally, Norges Bank purchased a new stake in Mettler-Toledo International in the 4th quarter valued at $372,954,000. 95.07% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

MTD has been the subject of several analyst reports. Evercore ISI upped their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a report on Monday, February 10th. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a report on Monday, April 7th. StockNews.com cut Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their price target for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Finally, Wells Fargo & Company increased their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a report on Monday, May 5th. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $1,296.13.

Insider Activity

In other news, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares of the company's stock, valued at approximately $964,248.46. This represents a 51.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.94% of the company's stock.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD traded up $15.57 during mid-day trading on Friday, reaching $1,158.93. 148,650 shares of the company's stock were exchanged, compared to its average volume of 146,526. The firm has a market capitalization of $24.09 billion, a price-to-earnings ratio of 28.59, a PEG ratio of 3.30 and a beta of 1.40. Mettler-Toledo International Inc. has a 52-week low of $946.69 and a 52-week high of $1,546.93. The company's 50-day moving average is $1,107.03 and its 200-day moving average is $1,218.69.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, topping the consensus estimate of $7.90 by $0.29. The business had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The business's quarterly revenue was down 4.6% on a year-over-year basis. During the same quarter last year, the company earned $8.89 EPS. As a group, equities analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.